Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

iBio, Inc. Director's Dealing 2011

Apr 14, 2011

35045_dirs_2011-04-14_7b608ac9-05f1-4764-b714-792c4aa71b68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2008-08-12

Reporting Person: KAY E GERALD (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6386595 Indirect

Footnotes

F1: Includes (i) 819,629 shares of common stock held by EGK LLC, of which the reporting person is the manager and (ii) 1,266,706 shares of common stock owned by Integrated BioPharma, Inc. of which the reporting person is a member of a control group. Shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Kay Sheppard with respect to 169,358 shares of common stock.